JunHe LLP, Healthcare (PRC Firms) | Chambers Greater China Region Profile

About

Provided by JunHe LLP

JunHe is a leading full-service law firm in China with a proven track record in advising domestic and foreign companies in the life sciences and healthcare sector. With over 30 years of experience, our multidisciplinary team offers expertise in mergers and acquisitions, capital markets, intellectual property, compliance, and dispute resolution. We provide regulatory services for clinical trials and product registrations, IP transaction services, and legal support for corporate finance, compliance, labor, taxation, and dispute resolution. Our unified internal management ensures comprehensive and high-quality services from our cross-sector and cross-regional lawyers.

Recent Major Deals:

Advised Elpiscience on its Research Collaboration and License Agreement with Astellas
Advised Grifols in the sale of a 20% equity stake in SRAAS and its strategic alliance with Haier Group and SRAAS
Advised Usynova in Granting a Global License for KRAS G12D Inhibitors to AstraZeneca
Assisted Huagai Capital to establish Huagai Medical RMB Fund IV
Advised Antengene on its Commercialization Partnership with Hansoh Pharma
Advised ImmuneOnco on its Listing on the HKEx
Advised Biocytogen on Its Technical Collaboration with Overseas Biopharmaceutical Companies
Advised Qyuns on its Listing on the Stock Exchange of Hong Kong

Chambers Review

Provided by Chambers

Healthcare (PRC Firms) - China

Band 3

What the Team is Known For

JunHe boasts a dedicated healthcare team acting for key clients in the pharmaceutical, medical devices and financial services sectors. It is capable of advising on licensing and partnership deals, as well as joint venture and investment matters. The firm utilises its strength in capital markets to handle domestic and overseas issuances.

Notable practitioners

Tao Xudong and Liu Ning are key client contacts.

业务优势

君合律师事务所拥有一支专注于医疗保健的法律团队，为制药、医疗器械和金融服务领域的关键客户提供服务。该团队能够就许可和合作协议以及合资企业和投资事项提供法律意见。君合能够利用其在资本市场的优势处理国内外的发行项目。

领先律师

陶旭东律师和刘宁律师是客户的关键联系人。

View ranking table

Work Highlights

Provided by JunHe LLP

JunHe advised Usynova Pharmaceuticals on its grant of a global licence for KRAS G12D Inhibitors to AstraZeneca.
君合律师事务所为祐森健恒就其向阿斯利康授予KRAS G12D抑制剂全球许可提供法律服务。

Strengths

Provided by Chambers

Junhe's team always replies very quickly with good quality. It always understands what we need and gives us the best solution. The team has good teamwork and can serve clients seamlessly.